Bill Tracker · South Dakota

HB1099

An Act to reschedule crystalline polymorph psilocybin in an FDA-approved drug product as a Schedule IV controlled substance

Status

Enacted

2026 Regular Session

IntroducedDate TBC (done)
PassedDate TBC (done)
SignedDate TBC (done)
Law in effectNext step (current)

Sponsor: Tom Pischke (Republican)
Type: Scheduling/Trigger Law
Substances: Psilocybin
Session dates: January 13, 2026 – March 30, 2026

Official text

Summary (from PoliPsy)

Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: sdlegislature.gov

Legislative history

March 10, 2026
Passed
March 10, 2026
Passed
March 2, 2026
Enrolled (Passed Both Chambers)
February 25, 2026
Committee Report
February 10, 2026
Referred
February 9, 2026
Engrossed (Passed One Chamber)
February 5, 2026
Committee Report
January 21, 2026
Referred
January 21, 2026
Introduced

Loading bill…